BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16786043)

  • 1. Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival results.
    Mascaux C; Martin B; Paesmans M; Berghmans T; Dusart M; Haller A; Lothaire P; Meert AP; Lafitte JJ; Sculier JP
    Br J Cancer; 2006 Jul; 95(2):139-45. PubMed ID: 16786043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cox-2 in non-small cell lung cancer: a meta-analysis.
    Jiang H; Wang J; Zhao W
    Clin Chim Acta; 2013 Apr; 419():26-32. PubMed ID: 23384501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p16 in non-small cell lung cancer and its prognostic significance: a meta-analysis of published literatures.
    Tong J; Sun X; Cheng H; Zhao D; Ma J; Zhen Q; Cao Y; Zhu H; Bai J
    Lung Cancer; 2011 Nov; 74(2):155-63. PubMed ID: 21621871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis.
    Mascaux C; Iannino N; Martin B; Paesmans M; Berghmans T; Dusart M; Haller A; Lothaire P; Meert AP; Noel S; Lafitte JJ; Sculier JP
    Br J Cancer; 2005 Jan; 92(1):131-9. PubMed ID: 15597105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A meta-analysis of STAT3 and phospho-STAT3 expression and survival of patients with non-small-cell lung cancer.
    Xu YH; Lu S
    Eur J Surg Oncol; 2014 Mar; 40(3):311-7. PubMed ID: 24332948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
    Zhu J; Li R; Tiselius E; Roudi R; Teghararian O; Suo C; Song H
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011300. PubMed ID: 29247502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Two-Gene Prognostic Classifier for Early-Stage Lung Squamous Cell Carcinoma in Multiple Large-Scale and Geographically Diverse Cohorts.
    Noro R; Ishigame T; Walsh N; Shiraishi K; Robles AI; Ryan BM; Schetter AJ; Bowman ED; Welsh JA; Seike M; Gemma A; Skaug V; Mollerup S; Haugen A; Yokota J; Kohno T; Harris CC
    J Thorac Oncol; 2017 Jan; 12(1):65-76. PubMed ID: 27613525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203.
    Edelman MJ; Watson D; Wang X; Morrison C; Kratzke RA; Jewell S; Hodgson L; Mauer AM; Gajra A; Masters GA; Bedor M; Vokes EE; Green MJ
    J Clin Oncol; 2008 Feb; 26(6):848-55. PubMed ID: 18281656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of EZH2 in Non-Small-Cell Lung Cancers: A Meta-Analysis and Bioinformatics Analysis.
    Fan K; Zhang CL; Qi YF; Dai X; Birling Y; Tan ZF; Cao F
    Biomed Res Int; 2020; 2020():2380124. PubMed ID: 33299862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of K-RAS mutations in patients with non-small cell lung cancer: a systematic review with meta-analysis.
    Meng D; Yuan M; Li X; Chen L; Yang J; Zhao X; Ma W; Xin J
    Lung Cancer; 2013 Jul; 81(1):1-10. PubMed ID: 23608713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-associated metabolic and inflammatory responses in early stage non-small cell lung cancer: Local patterns and prognostic significance.
    Millares L; Barreiro E; Cortes R; Martinez-Romero A; Balcells C; Cascante M; Enguita AB; Alvarez C; Rami-Porta R; Sánchez de Cos J; Seijo L; Monsó E;
    Lung Cancer; 2018 Aug; 122():124-130. PubMed ID: 30032820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis.
    Zhang B; Xie Z; Li B
    Gene; 2019 Mar; 689():76-83. PubMed ID: 30552981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF-C in non-small cell lung cancer: meta-analysis.
    Jiang H; Shao W; Zhao W
    Clin Chim Acta; 2014 Jan; 427():94-9. PubMed ID: 24144865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid transcription factor 1--a new prognostic factor in lung cancer: a meta-analysis.
    Berghmans T; Paesmans M; Mascaux C; Martin B; Meert AP; Haller A; Lafitte JJ; Sculier JP
    Ann Oncol; 2006 Nov; 17(11):1673-6. PubMed ID: 16980598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression profile and clinic significance of the SIX family in non-small cell lung cancer.
    Liu Q; Li A; Tian Y; Liu Y; Li T; Zhang C; Wu JD; Han X; Wu K
    J Hematol Oncol; 2016 Nov; 9(1):119. PubMed ID: 27821176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of ERCC1-C118T and -C8092A polymorphisms with lung cancer risk and survival of advanced-stage non-small cell lung cancer patients receiving platinum-based chemotherapy: a pooled analysis based on 39 reports.
    Xu TP; Shen H; Liu LX; Shu YQ
    Gene; 2013 Sep; 526(2):265-74. PubMed ID: 23727606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 genetic variants are associated with survival in unresectable locally advanced non-small cell lung cancer.
    Bi N; Yang M; Zhang L; Chen X; Ji W; Ou G; Lin D; Wang L
    Clin Cancer Res; 2010 Apr; 16(8):2383-90. PubMed ID: 20332326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of Basic Fibroblast Growth Factor (bFGF) in Lung Cancer: A Systematic Review with Meta-Analysis.
    Hu M; Hu Y; He J; Li B
    PLoS One; 2016; 11(1):e0147374. PubMed ID: 26824699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project.
    Berghmans T; Dusart M; Paesmans M; Hossein-Foucher C; Buvat I; Castaigne C; Scherpereel A; Mascaux C; Moreau M; Roelandts M; Alard S; Meert AP; Patz EF; Lafitte JJ; Sculier JP;
    J Thorac Oncol; 2008 Jan; 3(1):6-12. PubMed ID: 18166834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COX-2 overexpression and -8473 T/C polymorphism in 3' UTR in non-small cell lung cancer.
    Bhat IA; Rasool R; Qasim I; Masoodi KZ; Paul SA; Bhat BA; Ganaie FA; Aziz SA; Shah ZA
    Tumour Biol; 2014 Nov; 35(11):11209-18. PubMed ID: 25113252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.